Ligand-Driven Activation of the Notch Pathway in T-All and Solid Tumors: Why Not(ch)?

Cell Cycle - United States
doi 10.4161/cc.9.1.10346
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

The Notch/Hes1 Pathway Sustains NF-κB Activation Through CYLD Repression in T Cell Leukemia

Cancer Cell
Cancer ResearchOncologyCell Biology
2010English

A Review of Notch Processing With New Insights Into Ligand-Independent Notch Signaling in T-Cells

Frontiers in Immunology
AllergyImmunology
2018English

Comments on "Why Not Use It All?".

Environmental Health Perspectives
MutagenesisPublic HealthEnvironmentalHealthToxicologyOccupational Health
1999English

CAR T-Cell Therapy for Solid Tumors?

Cancer Discovery
Oncology
2018English

Adoptive T-Cell Therapy for Solid Tumors

American Society of Clinical Oncology educational book / ASCO. American Society of Clinical Oncology. Meeting
Medicine
2017English

Making CAR T Cells a Solid Option for Solid Tumors

Frontiers in Immunology
AllergyImmunology
2018English

Preclinical Testing of a Novel Personalized Cancer Vaccine for All Solid Tumors and All Patients

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2015English

The Roles of CD28 and CD40 Ligand in T Cell Activation and Tolerance

Journal of Immunology
AllergyImmunology
2000English

Dual Mechanism of Action of Resveratrol in Notch Signaling Pathway Activation in Osteosarcoma

Tropical Journal of Pharmaceutical Research
PharmacologyPharmaceutical Science
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy